T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.81B |
| 2 |
XYZ
Block Inc
XYZ
|
+$1.46B |
| 3 |
Accenture
ACN
|
+$1.23B |
| 4 |
Gilead Sciences
GILD
|
+$1.15B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.61B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.06B |
| 3 |
Tesla
TSLA
|
+$1.81B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.72B |
| 5 |
Amazon
AMZN
|
+$1.59B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.44% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.3% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Jones Lang LaSalle
JLL
$17B
| $10.5M | ﹤0.01% |
42,237
+2,297
| +6% | +$604K |
|
|
FOLD
1102
DELISTED
Amicus Therapeutics
FOLD
| $10.5M | ﹤0.01% |
1,283,066
-85,575
| -6% | -$792K |
|
|
SION
1103
Sionna Therapeutics
SION
$296M
| $10.4M | ﹤0.01% |
+996,212
| New | +$16.3M |
|
1104
Lyft
LYFT
$6.28B
| $10.3M | ﹤0.01% |
869,669
-400,534
| -32% | -$5.21M |
|
1105
MGM Resorts International
MGM
$11.1B
| $10.2M | ﹤0.01% |
344,410
-4,055
| -1% | -$136K |
|
1106
Fox Class B
FOX
$24.4B
| $10.2M | ﹤0.01% |
193,567
+9,567
| +5% | +$475K |
|
1107
Graco
GGG
$13.4B
| $10.1M | ﹤0.01% |
121,461
+12,002
| +11% | +$1.02M |
|
1108
SoFi Technologies
SOFI
$23.8B
| $10.1M | ﹤0.01% |
869,763
-648,378
| -43% | -$9.34M |
|
1109
Seadrill
SDRL
$2.92B
| $10.1M | ﹤0.01% |
404,385
-7,237
| -2% | -$224K |
|
1110
Mueller Water Products
MWA
$4.09B
| $9.94M | ﹤0.01% |
391,156
+55,581
| +17% | +$1.39M |
|
1111
Veeco
VECO
$3.26B
| $9.57M | ﹤0.01% |
476,646
+2,255
| +0.5% | +$54K |
|
1112
Rithm Capital
RITM
$5.71B
| $9.5M | ﹤0.01% |
829,323
+130,367
| +19% | +$1.51M |
|
1113
IES Holdings
IESC
$15.3B
| $9.49M | ﹤0.01% |
57,478
+54,180
| +1,643% | +$11.3M |
|
1114
Reinsurance Group of America
RGA
$16.1B
| $9.42M | ﹤0.01% |
47,845
-17,198
| -26% | -$3.56M |
|
1115
Old Republic International
ORI
$10.3B
| $9.41M | ﹤0.01% |
240,001
+7,984
| +3% | +$293K |
|
1116
BioMarin Pharmaceuticals
BMRN
$13.6B
| $9.36M | ﹤0.01% |
132,349
-460,044
| -78% | -$30.9M |
|
|
DAWN
1117
DELISTED
Day One Biopharmaceuticals
DAWN
| $9.3M | ﹤0.01% |
1,173,094
-533,018
| -31% | -$5.74M |
|
1118
Fulton Financial
FULT
$4.67B
| $9.24M | ﹤0.01% |
510,655
+346,611
| +211% | +$6.75M |
|
1119
Illumina
ILMN
$29.1B
| $9.23M | ﹤0.01% |
116,376
+8,028
| +7% | +$869K |
|
1120
Pharvaris
PHVS
$2.55B
| $9.2M | ﹤0.01% |
586,087
+142,191
| +32% | +$2.4M |
|
1121
CONMED
CNMD
$1.49B
| $9.14M | ﹤0.01% |
151,361
+1,691
| +1% | +$109K |
|
1122
Transmedics
TMDX
$3.02B
| $9.13M | ﹤0.01% |
135,698
-122,947
| -48% | -$8.46M |
|
1123
Relay Therapeutics
RLAY
$4.4B
| $9.11M | ﹤0.01% |
3,477,791
+156,050
| +5% | +$611K |
|
1124
Inspire Medical Systems
INSP
$1.68B
| $8.99M | ﹤0.01% |
56,414
-1,518
| -3% | -$275K |
|
1125
Full Truck Alliance
YMM
$9.2B
| $8.91M | ﹤0.01% |
697,661
| – | – |
|
Similar funds
T. Rowe Price Associates's Q1 2025 Portfolio in Review
As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
- T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
- T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
- T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
- T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
- T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.
Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.